ImmuPharma PLC (UK) Probability of Future Stock Price Finishing Over 12.37
| IMM Stock | 1.19 0.24 16.78% |
ImmuPharma |
ImmuPharma PLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ImmuPharma PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ImmuPharma PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ImmuPharma PLC generated a negative expected return over the last 90 days | |
| ImmuPharma PLC may become a speculative penny stock | |
| ImmuPharma PLC has high historical volatility and very poor performance | |
| ImmuPharma PLC has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.92 M) with profit before overhead, payroll, taxes, and interest of 118.35 K. | |
| ImmuPharma PLC generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
ImmuPharma PLC Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ImmuPharma Stock often depends not only on the future outlook of the current and potential ImmuPharma PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ImmuPharma PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 362 M | |
| Cash And Short Term Investments | 208.5 K |
ImmuPharma PLC Technical Analysis
ImmuPharma PLC's future price can be derived by breaking down and analyzing its technical indicators over time. ImmuPharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ImmuPharma PLC. In general, you should focus on analyzing ImmuPharma Stock price patterns and their correlations with different microeconomic environments and drivers.
ImmuPharma PLC Predictive Forecast Models
ImmuPharma PLC's time-series forecasting models is one of many ImmuPharma PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ImmuPharma PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ImmuPharma PLC
Checking the ongoing alerts about ImmuPharma PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ImmuPharma PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ImmuPharma PLC generated a negative expected return over the last 90 days | |
| ImmuPharma PLC may become a speculative penny stock | |
| ImmuPharma PLC has high historical volatility and very poor performance | |
| ImmuPharma PLC has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.92 M) with profit before overhead, payroll, taxes, and interest of 118.35 K. | |
| ImmuPharma PLC generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
Other Information on Investing in ImmuPharma Stock
ImmuPharma PLC financial ratios help investors to determine whether ImmuPharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ImmuPharma with respect to the benefits of owning ImmuPharma PLC security.